Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Methods in Molecular Biology (Clifton, N.J.)|June 11, 2009
BacMam: versatile gene delivery technology for GPCR assaysElizabeth A Davenport, Parvathi Nuthulaganti, Robert S AmesJournal of Biomolecular Screening|March 16, 2010
Development of a high-throughput cell-based assay for superoxide production in HL-60 cellsPatricia M Seitz, Rona Cooper, Gregory J Gatto, et al.Bioorganic & Medicinal Chemistry Letters|June 15, 2010
Benzofuran-substituted urea derivatives as novel P2Y(1) receptor antagonistsReema K Thalji, Nambi Aiyar, Elizabeth A Davenport, et al.American Journal of Physiology. Renal Physiology|June 20, 2008
AMTB, a TRPM8 channel blocker: evidence in rats for activity in overactive bladder and painful bladder syndromeErin S R Lashinger, Matthew S Steiginga, J Paul Hieble, et al.Journal of Biomolecular Screening|May 31, 2012
The development of a high-content screening binding assay for the smoothened receptorWeilin Tiger Bee, Wensheng Xie, Maggie Truong, et al.The Journal of Pharmacology and Experimental Therapeutics|March 24, 2009
Evidence for allosteric interactions of antagonist binding to the smoothened receptorCynthia M Rominger, Wei-Lin Tiger Bee, Robert A Copeland, et al.Bioorganic & Medicinal Chemistry Letters|October 18, 2008
Tetrahydro-4-quinolinamines identified as novel P2Y(1) receptor antagonistsAngel I Morales-Ramos, John S Mecom, Terry J Kiesow, et al.Bioorganic & Medicinal Chemistry Letters|July 27, 2013
The discovery of potent blockers of the canonical transient receptor channels, TRPC3 and TRPC6, based on an anilino-thiazole pharmacophoreDavid G Washburn, Dennis A Holt, Jason Dodson, et al.Science Translational Medicine|November 9, 2012
An orally active TRPV4 channel blocker prevents and resolves pulmonary edema induced by heart failureKevin S Thorneloe, Mui Cheung, Weike Bao, et al.Pageof 1